Laurie Sellars joins Ethics Talk to discuss her article, coauthored with Dr Jeff Sebo: “How Should Treatment of Animals Beyond the Lab Factor Into Institutional Review?”

Clinicians should know how randomized controlled trials can and cannot contribute to advancing health equity for transgender and gender diverse people.

Dr David DeGrazia joins Ethics Talk to discuss why the “3 R’s” of nonhuman animal research might not be sufficient to promote good science, ethics, and nonhuman animal welfare.

This visual considers how nonhuman primates offer unique research value due to their evolutionary proximity to humans.

Ethically justifying human-centered research with only nonhuman animals as subjects likely requires that the research’s benefits to humans must, at least, outweigh harms suffered by the nonhuman animals.

Antibiotics can be compared to other forms of “tragedy of the commons,” whereby a common good (effective treatment of infections) is jeopardized by individual consumption and lack of stewardship.

Patients living in low-and middle-income countries (LMICs) shoulder the greatest burden of infections caused by antimicrobial-resistant pathogens.

Devin Hunt joins Ethics Talk to discuss his article, coauthored with Dr Olivia S. Kates: "A Brief History of Antimicrobial Resistance.”

Resistance has dogged infectious disease treatment processes since we started using modern antimicrobials.

Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab.